Lilly’s retatrutide delivers more than twice Ozempic weight loss
By: | Published: 2026-10-31 15:14:25 | Source: www.atlanticcitynews.net
INDIANAPOLIS, Indiana: Eli Lilly’s experimental obesity drug retatrutide delivered more than twice the weight loss achieved with Novo Nordisk’s Ozempic while also producing better blood sugar control in a late-stage diabetes trial, the company said.
Place your ad here (700×100)
Patients receiving the higher, 12 mg dose of retatrutide lost 20.9% of their weight after 80 weeks, compared with 9.4% among those…

